ROYALTIES ON NET SALES OF THE PRODUCTS Sample Clauses

ROYALTIES ON NET SALES OF THE PRODUCTS. In consideration of the licenses granted to SC, SC shall pay to GTC a royalty in the amount of (i) * on cumulative Net Sales by SC, its Affiliates and sublicensees of less than * and (ii) * on cumulative Net Sales by SC, its Affiliates and sublicensees equal to or greater than * . In the event that a Product comprises a Lead Compound or derivatives or analogues thereof initially discovered to have activity against a GTC-identified target during the first * Contract Years, the royalty rate on Net Sales of such Product payable pursuant to the preceding sentence shall be increased by * .
Sample 1Sample 2
AutoNDA by SimpleDocs
ROYALTIES ON NET SALES OF THE PRODUCTS. In consideration of the licenses granted to AHP, AHP shall pay to GTC a royalty on annual Net Sales by AHP, its Affiliates and sublicensees as follows: ***
Sample 1
ROYALTIES ON NET SALES OF THE PRODUCTS. In consideration of the licenses granted to SC, SC shall pay to GTC a royalty in the amount of (i) [*] on cumulative Net Sales by SC, its Affiliates and sublicensees of Products for which human trials are initiated on or before [*] (ii) [*] on cumulative Net Sales by SC, its Affiliates and sublicensees of Products for which human trials are initiated on or after [*] and (iii) with respect to sales of [*] in any country in the world by SC, its Affiliates and sublicensees, the sale or manufacture of which would infringe in the country of sale or manufacture, but for the license granted to SC hereunder, a Valid Claim included in a Product Patent Right, an additional [*] of Net Sales on the royalty rates set forth in clause (i) or (ii) of this Section in each country in which such Product Patent Right exists.
Sample 1
ROYALTIES ON NET SALES OF THE PRODUCTS. As additional compensation to -------------------------------------- IGI for the supply of Product to GW, and as payment for use of the Trademark pursuant to Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omissions. the Trademark License granted to GW hereunder, GW shall pay or cause to be paid to IGI a royalty on the aggregate of all GW Net Sales of Products in the Territory, using the royalty rates as determined below:
Sample 1

Related to ROYALTIES ON NET SALES OF THE PRODUCTS

  • Royalties on Net Sales Novo will pay to Neose royalties as a percentage of annual Net Sales of each New Product during the Term at the applicable rates set forth in this Section 4.1 and in accordance with this Section 4:

  • Net Sales The term “

  • Sublicense Revenue In the event Licensee or an Affiliate of Licensee sublicenses under Section 2.2, Licensee shall pay CareFusion **THE CONFIDENTIAL PORTION HAS BEEN SO OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION.** of any Sublicense Revenues resulting from sublicense agreements executed by Licensee.

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Combination Products If a LICENSED PRODUCT is sold to any third party in combination with other products, devices, components or materials that are capable of being sold separately and are not subject to royalties hereunder (“OTHER PRODUCTS,” with the combination of products being referred to as “COMBINATION PRODUCTS” and the Other Product and Licensed Product in such Combination Product being referred to as the “COMPONENTS”), the NET SALES of such LICENSED PRODUCT included in such COMBINATION PRODUCT shall be calculated by multiplying the NET SALES of the COMBINATION PRODUCT by the fraction A/(A+B), where A is the average NET SALES price of such LICENSED PRODUCT in the relevant country, as sold separately, and B is the total average NET SALES price of all OTHER PRODUCTS in the COMBINATION PRODUCT in the relevant country, as sold separately. If, in any country, any COMPONENT is not sold separately, NET SALES for royalty determination shall be determined by the formula [C / (C+D)], where C is the aggregate average fully absorbed cost of the Licensed Product components during the prior Royalty Period and D is the aggregate average fully absorbed cost of the other essential functional components during the prior Royalty Period, with such costs being determined in accordance with generally accepted accounting principles. To the extent that any SUBLICENSE INCOME relates to a COMBINATION PRODUCT or is otherwise calculated based on the value of one or more licenses or intellectual property rights held by the COMPANY, an AFFILIATE or SUBLICENSEE, COMPANY shall determine in good faith and report to THE PARTIES the share of such payments reasonably attributable to COMPANY’s or such AFFILIATE’s sublicense of the rights granted hereunder, based upon their relative importance and proprietary protection, which portion shall be the SUBLICENSE INCOME. THE PARTIES shall have the right to dispute such sharing determination in accordance with the dispute provisions of the AGREEMENT.

  • Royalties 8.1 In consideration of the license herein granted, LICENSEE shall pay royalties to LICENSOR as follows:

  • Milestone Payments In addition to the payments set forth in Sections 4.1 through 4.3 above, Company shall pay Hospital milestone payments as follows:

  • Sales Milestone Payments Licensee shall notify MTI of any Calendar Year in which annual Net Sales of a Licensed Product in such Calendar Year in all countries in the Territory reach the following thresholds for the first time within [***] days after the end of such Calendar Year, and shall make the following sales milestone payments to MTI within [***] days after receiving an invoice from MTI therefor: Annual Net Sales Threshold Sales Milestone Payment [***] [***] [***] [***] [***] [***] Each sales milestone payment is separate and may only be earned once for each Licensed Product, irrespective of the number of times such thresholds are achieved for such Licensed Product, but if more than one Net Sales threshold is reached in the same Calendar Year, all corresponding sales milestone payments shall be payable during such Calendar Year. For example, if annual Net Sales of a Licensed Product first reach [***] dollars [***] in Calendar Year 1, [***] dollars [***] shall be payable to MTI for such Calendar Year 1, however, if annual Net Sales of a Licensed Product first reach [***] dollars ($500,000,000) in Calendar Year 2 [***] Portions of this exhibit have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. (without first reaching [***] dollars [***] in Calendar Year 1), then both the [***] dollars [***] and the [***] dollars [***] sales milestone payments would be payable to MTI for such Calendar Year 2. Net Sales of the Co-Exploited Product in the United States, which are subject to profit and loss sharing pursuant to the Co-Exploitation Terms, shall be excluded from the annual Net Sales of such Co-Exploited Product for purposes of this Section 7.10.

  • Third Party Royalties Each party shall be responsible for all of its own costs of commercializing Products or licensing Intellectual Property Rights, including any payments to Third Parties for work done by such Third Parties or for licenses necessary for the manufacture, sale, or use of Products by a party or its Affiliates or sublicensees.

Time is Money Join Law Insider Premium to draft better contracts faster.